Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig L Slingluff

Showing results (141-150 of 226) with videos related to

Pageof 23
Sort By:
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Annals of Surgical Oncology|August 9, 2019
Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal MetastasisMinyoung Kwak, Yun Song, Phyllis A Gimotty, et al.
Oncoimmunology|July 30, 2016
Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrateSylvain Ladoire, Laura Senovilla, David Enot, et al.
Clinical Trials (London, England)|July 3, 2010
Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trialsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Cells|December 24, 2021
Proliferating CD8<sup>+</sup> T Cell Infiltrates Are Associated with Improved Survival in GlioblastomaIleana S Mauldin, Jasmin Jo, Nolan A Wages, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugatesArabinda Mandal, Jagathpala Shetty, Christine A Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2026
Impact of GM-CSF and two-site vaccination on clinical outcomes after multipeptide vaccination for melanoma: long-term analysis of a randomized phase II trialEmily K Ninmer, Hong Zhu, Amrita Sarkar, et al.
Annals of Surgery|August 20, 2019
The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and AngiogenesisKatie M Leick, Anthony B Rodriguez, Marit M Melssen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2Kimberly A Chianese-Bullock, Elizabeth M H Woodson, Huimin Tao, et al.
International Journal of Cancer|September 4, 2021
A pilot trial of vaccination with Carcinoembryonic antigen and Her2/neu peptides in advanced colorectal cancerKevin T Lynch, Gabriella C Squeo, William J Kane, et al.
Pageof 23

Showing results (141-150 of 226) with videos related to

Sort By:
Pageof 23
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Annals of Surgical Oncology|August 9, 2019
Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal MetastasisMinyoung Kwak, Yun Song, Phyllis A Gimotty, et al.
Oncoimmunology|July 30, 2016
Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrateSylvain Ladoire, Laura Senovilla, David Enot, et al.
Clinical Trials (London, England)|July 3, 2010
Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trialsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Cells|December 24, 2021
Proliferating CD8<sup>+</sup> T Cell Infiltrates Are Associated with Improved Survival in GlioblastomaIleana S Mauldin, Jasmin Jo, Nolan A Wages, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugatesArabinda Mandal, Jagathpala Shetty, Christine A Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2026
Impact of GM-CSF and two-site vaccination on clinical outcomes after multipeptide vaccination for melanoma: long-term analysis of a randomized phase II trialEmily K Ninmer, Hong Zhu, Amrita Sarkar, et al.
Annals of Surgery|August 20, 2019
The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and AngiogenesisKatie M Leick, Anthony B Rodriguez, Marit M Melssen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2Kimberly A Chianese-Bullock, Elizabeth M H Woodson, Huimin Tao, et al.
International Journal of Cancer|September 4, 2021
A pilot trial of vaccination with Carcinoembryonic antigen and Her2/neu peptides in advanced colorectal cancerKevin T Lynch, Gabriella C Squeo, William J Kane, et al.
Pageof 23